TLB Special: Toxic Aluminum, Alzheimer’s & Breakthrough Science – With Dr. Christopher Exley
Click on the TLB Radio Logo to hear this recorded show.
Preface by: Roger Landry (TLB), Show Host
Today we as a society are literally surrounded and bombarded by toxins from the air we breath, the food we eat, the medications we take, the vaccinations we receive, the cosmetics we apply, the water we drink and more.
One of the biggest and most abundant of these toxins is Aluminum. As a result we are seeing the biggest surge in Cancers, Cognitive Dysfunctions and Autoimmune diseases in history, with most exploding in occurrence.
Now we offer you a true Multimedia look at the topic Aluminum and the Human Physiology. We start off with a brilliant article authored by TLB Staff Writer Christina England (my co-host for this excellent discussion) covering the aluminum issue and the phenomenal work being accomplished by Dr. Christopher Exley (including several videos), followed by a recorded discussion with Dr. Exley himself.
Please read, watch and listen …
Scientists From Keele University May Have Discovered a Natural Cure for Alzheimer’s Disease
By TLB Staff Writer: Christina England
Aluminum has been named as the second most used metal in the world after steel, largely because it is so versatile. It can be found in our food, drinking water, atmosphere, medication, vaccinations and cosmetics.
According to U.S. Department of Energy, the United States’ aluminum industry is the world’s largest, processing 9.6 million metric tons of metal and producing about $40 billion in products and exports in 2003.
However, despite its versatility and its many uses, aluminum has become one of most negatively talked about products used today. In recent months, scientists have linked its use to cancer, Gulf War Syndrome, ASIA, autism, Alzheimer’s disease and chemical burns.
Exciting News for Those Suffering with Alzheimer’s Disease
As many of us are aware, aluminum is extremely versatile. It has been regularly used as an ingredient in vaccinations, cosmetics, drugs, baby formulas, antiperspirants, pesticides and soda cans for many years. However, very few of us are aware of its effects on the human body.
Professor Christopher Exley, often referred to as Mr. Aluminum, has been studying the effects of aluminum on the human body for thirty years and has become increasingly worried. In a recent video presentation, he explained that, despite the fact that aluminum has been regularly used as an adjuvant in vaccination for many years, little is known about its effect on the human body. He made it clear that we should accept that aluminum is toxic and that toxicity may take many different forms. He stated that wherever it ends up in the body, it has the potential to do harm.
Professor Exley continued by stating that:
“If aluminum is in the brain, it can produce neurodegeneration and problems associated with the brain; if it is in the bone, it can produce bone disease. Wherever it ends up in the body, it has the potential to cause toxicity, whether it is in humans, fish or any other living organism.”
One of the known effects of aluminum toxicity is Alzheimer’s Disease and in 2006, Professor Exley and his team wrote a paper titled Non-invasive therapy to reduce the body burden of aluminum in Alzheimer’s, in which the team discussed ways to reduce the body burden of aluminum in patients with Alzheimer’s disease.
They wrote that:
“Based upon the premise that urinary aluminium is the best non-invasive estimate of body burden of aluminium patients with Alzheimer’s disease were asked to drink 1.5 L of a silicic acid-rich mineral water each day for five days and, by comparison of their urinary excretion of aluminium pre-and post this simple procedure, the influence upon their body burden of aluminium was determined.”
For the purpose of their study, the team used the mineral water Volvic, because of its high concentrations of the mineral silicic acid, which Professor Exley says can reduce body burden of aluminum through the urine if drank regularly. He believed that by reducing the body burden of aluminum in patients with Alzheimer’s disease, this process may slow down the diseases progression.
On page 18 of the paper they wrote that:
“The primary objective in Week 1 was to obtain an estimate of the patient’s normal urinary Al excretion. Patients were provided with pristine airtight sample bottles and asked to collect their first urine of each of five consecutive days. It was neither practical nor ethically acceptable to ask patients to collect 24 hour urine samples. However, the use of ‘spot’ samples to estimate urinary Al excretion was validated as explained in Section 2.2 below. The urine samples were stored in appropriate biohazard bags in the patient’s refrigerator before being collected, transported to the laboratory and frozen at −20◦C. In Week 2 patients were asked to drink up to 1.5 L of silicic acid-rich mineral water (hereafter referred to by its brand name ‘Volvic’) per day for each of five consecutive days. Once again, beginning with the first day which followed drinking the first 1.5 L of Volvic, the patients were asked to collect their first urine sample of the day and to repeat this for five consecutive days. Storage, collection, transport and treatment of urine samples were as per Week 1. In this way we collected five pre-Volvic (Week 1) and five post-Volvic (Week 2) urine samples for each of the ten patients. Patients completed record cards on which they indicated how much Volvic they drank on each day and whether or not they drank it neat or used it to make other beverages. Patients were not asked to drink the 1.5 L of Volvic as an additional constituent of their daily diets but to include it as part of their diets for that week. Apart from drinking Volvic in Week 2 the patients were encouraged to carry out their normal daily routines and to adhere to their usual diets.”
The results of their study were reported to be very encouraging and have spurred the team to do more work in the future.
The team concluded that:
“We have carried out the first study to determine if silicic acid in a potable water might be used to reduce the body burden of Al in individuals with AD. While the small number of participants must imply that our results are preliminary the statistical significance achieved for the Volvic-facilitated reduction of the body burden of Al is encouraging and future research will both increase the number of study participants and extend the period of time over which therapy is administered. A final aim is, of course, to determine if lowering the body burden of Al has any influence upon the incidence, progression and aetiology of AD.”
If it were possible to influence the progression of Alzheimer’s disease, might it be possible to slow down the progression of other disorders that aluminum has been linked to?
Sadly, to enable scientists such as Professor Exley and his team to gain the scientific data and knowledge required, they would need this research to be funded.
Public Appeal for Exciting New Research
On July 14, 2015, Professor Exley launched an appeal to the public titled The Peoples Trial The First Clinical Trial to Test the Aluminium / Alzheimer’s Disease Hypothesis to enable further research to proceed. In his video, he explained that as yet, a cure for Alzheimer’s disease has not been found. This is because scientists do not know the cause of the disease. He believes that if he and his team were able to carry out further research on the known links between Alzheimer’s disease and aluminum, then it may be possible to slow down the progression of the disease.
He stated that:
“One factor which has been linked to Alzheimer’s disease for actually 50 years now is human exposure to aluminum, exposure to aluminum in our everyday life. However, in all that time there has never been a clinical trial to test whether our exposure to aluminum in our everyday life contributes to Alzheimer’s disease. The idea therefore in this trial, is to test this hypothesis, that aluminum has a role to play in the disease.”
Professor Exley explained how he and his team propose to recruit individuals suffering from the early stages of Alzheimer’s disease and ask them to drink a litre of silicon-rich mineral water every day for two years and monitor the progress of their disease. He stated:
If this trial is successful, for example in demonstrating a role of aluminum in Alzheimer’s disease, then not only will we have shown that aluminum plays a role but we will have an effective treatment, we will have the first effective treatment.
Of course, if the team is successful, then their work could potentially pave the way for further trials examining the link between aluminum and other neurological conditions, including autism, Tourette syndrome and epilepsy.
Sadly, as yet, Professor Exley has been unable to secure the necessary funding that he and his team would require to carry out such a trial and he now believes that an appeal to the public may be only the way that they will be able to carry out their work.
In a press release advertising the appeal he stated that:
“This is why we are asking for the public’s help to support and fund a clinical trial which will establish once and for all if human exposure to aluminium is a contributory factor in Alzheimer’s disease.
Full details of the proposed clinical trial, the funding required to carry it out and how the public can support the trial by making a donation are all available through the following website; www.futsci.com or here …
For the specific purpose of raising funds for this important and historical clinical trial Professor Exley is collaborating with the Children’s Medical Safety Research Institute (CMSRI) which is a registered 501(C)(3) non-profit organisation where he is a member of the Scientific Advisory Board. The CMSRI guarantees that 100% of net proceeds raised through this appeal will be made available for this clinical trial.
The Liberty Beacon Radio Network was very excited to be able to speak to Professor Christopher Exley about his exciting work and the forthcoming project. The show was presented by founder of the Liberty Beacon Project Mr. Roger Landry and co-host Research Journalist Christina England.
For more information on the dangers of aluminum please see my full article Scientists Researching the Effect of Aluminum Exposure Appeal to the Public on The Liberty Beacon.
Please visit Children’s Medical Safety Research Institute (CMSRI) for much more information and to donate to this vital research.